Mohideen Pharis 4

What Happened
Mohideen Pharis, Chief Medical Officer of DBV Technologies S.A. (DBVT), sold 534 ordinary shares on January 29, 2026 at $4.86 per share, generating proceeds of $2,595. The filing lists the transaction as an open market or private sale (code S) and notes the shares were sold to satisfy withholding tax obligations upon the vesting of restricted stock units.

Key Details

• Transaction date and price: 2026-01-29 — 534 shares at $4.86 each. Total proceeds: $2,595.
• Reason for sale: Sold to satisfy tax withholding on RSU vesting (footnote F2).
• Shares owned after transaction: Not disclosed in the filing.
• Filing date: Form 4 filed Feb 2, 2026 (accession 0001760395-26-000002). No late-filing indication provided.
• Other footnotes: F1 — ordinary shares may be represented by American Depositary Shares (1 ADS = 5 ordinary shares). F3 — references a EUR→USD conversion rate used ($1.1974/EUR) for reporting an exercise price in USD.

Context
Tax-withholding sales tied to RSU vesting are routine and typically reflect tax obligations rather than a deliberate market view. This was a sale (not a purchase or option exercise) and therefore is generally less informative about insider sentiment.